Chemistry
Point Group D3
100%
Agonist
83%
Point Group D2
66%
Antagonist
50%
Dopamine
33%
Dopamine Receptor Stimulating Agent
33%
Dose
25%
Methyl
25%
% Inhibition
16%
Nafadotride
16%
Reaction Selectivity
16%
R
16%
Amine
8%
Ethyl
8%
Quinpirole
8%
Piperazine
8%
Bromocriptine
8%
Ester
8%
Haloperidol
8%
Methanesulfonate
8%
Apomorphine
8%
Pyridine
8%
Hydrobromide
8%
Mianserin
8%
Diamine
8%
Physostigmine
8%
Cholinergic
8%
1H-Indole
8%
Benzamide
8%
Maleate
8%
Butanone
8%
Quinoline
8%
1,2,3,4-tetrahydroisoquinoline
8%
Naphthalenecarboxamide
8%
Ergotaman
8%
5,6-dimethoxy-N,N-dipropyl-2,3-dihydro-1H-inden-2-amine
8%
Pramipexole
8%
6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol
8%
Scopolamine
8%
Azepine
8%
Procedure
8%
Potential
8%
Acid
8%
Pharmacology, Toxicology and Pharmaceutical Science
Dopamine Receptor Stimulating Agent
33%
Receptor
25%
Rat
25%
Dopamine
16%
Amine
16%
Quinpirole
16%
Dopamine 3 Receptor
16%
Piperazine
16%
Haloperidol
16%
3,4,4a,10b Tetrahydro 4 Propyl 2h,5h [1]benzopyrano[4,3 b][1,4]oxazin 9 Ol
16%
Nafadotride
16%
Bromocriptine
8%
Pyridine
8%
Propane
8%
Ester
8%
Apomorphine
8%
Indole
8%
Benzamide
8%
Methanesulfonic Acid
8%
Pramipexole
8%
Mianserin
8%
Maleic Acid
8%
Cholinergic Receptor Stimulating Agent
8%
Quinazoline
8%
Scopolamine
8%
Bromide
8%
Physostigmine
8%
U-Shaped Dose Response
8%
Diamine
8%
Phenylacetic Acid
8%
Quinelorane
8%
Eseroline
8%
2 Dipropylamino 7 Hydroxytetralin
8%
Tetrahydroisoquinoline
8%
Azepine Derivative
8%
Quinoline
8%